These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10091652)

  • 1. The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.
    Kurapkat G; Siedentop M; Gattner HG; Hagelstein M; Brandenburg D; Grötzinger J; Wollmer A
    Protein Sci; 1999 Mar; 8(3):499-508. PubMed ID: 10091652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
    Zoete V; Meuwly M; Karplus M
    J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
    Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
    Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor binding redefined by a structural switch in a mutant human insulin.
    Hua QX; Shoelson SE; Kochoyan M; Weiss MA
    Nature; 1991 Nov; 354(6350):238-41. PubMed ID: 1961250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
    Whittingham JL; Youshang Z; Záková L; Dodson EJ; Turkenburg JP; Brange J; Dodson GG
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):505-11. PubMed ID: 16627943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies on des-pentapeptide (B26-30)-insulin. V. High resolution NMR studies.
    Sci Sin; 1976; 19(4):497-504. PubMed ID: 10624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insulin with the native sequence but virtually no activity.
    Wollmer A; Gilge G; Brandenburg D; Gattner HG
    Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
    Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
    Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
    Pittman I; Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix.
    Olsen HB; Ludvigsen S; Kaarsholm NC
    J Mol Biol; 1998 Nov; 284(2):477-88. PubMed ID: 9813131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural switch in a mutant insulin exposes key residues for receptor binding.
    Ludvigsen S; Olsen HB; Kaarsholm NC
    J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
    Sievert D; Gattner HG; Lenz V; Höcker H
    Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
    Hua QX; Weiss MA
    Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue.
    Hua QX; Hu SQ; Frank BH; Jia W; Chu YC; Wang SH; Burke GT; Katsoyannis PG; Weiss MA
    J Mol Biol; 1996 Nov; 264(2):390-403. PubMed ID: 8951384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.